Pfizer and BioNTech have asked U.S. regulators to approve emergency use of their Covid-19 vaccine for children ages 5 to 11. The move comes at a time when children are heading back to school and ...
The Pfizer/BioNTech bivalent COVID-19 vaccine (both Original and Omicron BA.4/BA.5) is already FDA-authorized under an EUA for use in individuals 12 years old and above as a single booster dose ...
The federal Centers for Disease Control and Prevention has added the Covid-19 vaccine to the recommended immunization schedule for children and adolescents. The Advisory Committee on Immunization ...
(The Hill) — The Food and Drug Administration (FDA) on Tuesday announced it was simplifying its recommended COVID-19 vaccine schedule, stating a single dose of the bivalent vaccine specific to ...
The company will submit an Emergency Use Authorization request soon. Data shows the Pfizer and BioNTech COVID-19 vaccine is safe and effective for children ages 5 to 11, the companies announced ...
“This decision comes at a time when Covid-19 cases are once again climbing,” Bourla said The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
T he COVID vaccine may be linked to a small increase in stroke risk when given with a high-dose flu shot, primarily in ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
WATCH: Nobel in medicine goes to scientists whose work on mRNA led to COVID vaccine Hungarian-American Katalin Karikó and American Drew Weissman were cited for contributing vaccine development ...
Moderna (NASDAQ:MRNA) announced Tuesday its next-generation COVID-19 vaccine mRNA-1283 reached the primary endpoints in a Phase 3 trial, outperforming the company’s FDA-approved COVID shot mRNA ...
(Reuters) -The U.S. health regulator on Monday proposed the use of one dose of the latest updated COVID-19 shot annually for healthy adults, similar to the influenza immunization campaign, as it ...